Bioventix (LON:BVXP) Insider Peter John Harrison Purchases 1,065 Shares

Bioventix PLC (LON:BVXP) insider Peter John Harrison purchased 1,065 shares of the firm’s stock in a transaction on Wednesday, April 8th. The stock was acquired at an average price of GBX 1,849 per share, with a total value of £19,691.85.

Bioventix Stock Performance

Shares of LON BVXP opened at GBX 1,890 on Friday. Bioventix PLC has a 52-week low of GBX 1,300 and a 52-week high of GBX 3,020. The firm has a 50 day moving average price of GBX 1,602.29 and a two-hundred day moving average price of GBX 1,883.90. The stock has a market cap of £98.75 million, a P/E ratio of 13.45 and a beta of 0.48.

Bioventix (LON:BVXP) last announced its quarterly earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. The firm had revenue of GBX 615.88 billion during the quarter. Analysts predict that Bioventix PLC will post 166.3066955 earnings per share for the current fiscal year.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.